Arabic Arabic English English French French German German
dark

Medicare mulls coverage for controversial Alzheimer’s drug

(Healthday)—Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer’s drug whose high price tag and unproven benefits have prompted widespread controversy. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Mechanical stimuli significantly influence organ growth

Next Post

What you say in the first minute after a vaccine can be key in reducing a child’s distress

Related Posts
Total
0
Share